Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SBGC-fortified fluoride varnish is an investigational dental combination product developed by The University of Hong Kong for the prevention of root caries in older adults. The formulation consists of a 5% sodium fluoride varnish (Duraphat) supplemented with 7.5% strontium-doped bioactive glass (SBGC). The mechanism of action involves the synergistic release of fluoride, strontium, and calcium ions, which promote the remineralization of the tooth root surface. This process leads to the formation of strontium-substituted-hydroxyapatite and strontium-substituted-fluorohydroxyapatite, which exhibit enhanced bioactivity and reduced acid solubility compared to natural tooth mineral. It is currently being evaluated in a 36-month randomized double-blind controlled clinical trial.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fluoride varnish + strontium-doped bioactive glass.